{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:20:50Z","timestamp":1782822050073,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.pnpbp.2007.10.020","type":"journal-article","created":{"date-parts":[[2007,11,2]],"date-time":"2007-11-02T12:28:00Z","timestamp":1194006480000},"page":"568-575","source":"Crossref","is-referenced-by-count":92,"title":["Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers"],"prefix":"10.1016","volume":"32","author":[{"given":"Laure","family":"Buydens-Branchey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Branchey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Hibbeln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.10.020_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1051\/rnd:2004063","article-title":"Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life","volume":"44","author":"Alessandri","year":"2004","journal-title":"Reprod Nutr Dev"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.jcp.0000246214.49271.f1","article-title":"N-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers","volume":"26","author":"Buydens-Branchey","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib3","doi-asserted-by":"crossref","unstructured":"Buydens-Branchey L, Branchey M. Long chain n-3 polyunsaturated fatty acids treatment decreases feelings of anger in substance abusers. Psychiatry Res in press. doi:10.1016\/j.psychres.2007.01.004.","DOI":"10.1016\/j.psychres.2007.01.004"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib4","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib5","series-title":"Structured Clinical Interview for DSM IV Axis I Disorders (SCID-I)","author":"First","year":"1997"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.188.1.46","article-title":"Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study","volume":"188","author":"Frangou","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib7","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4088\/JCP.v67n1217","article-title":"Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry","volume":"67","author":"Freeman","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3956(03)00077-3","article-title":"A placebo-controlled cross-over trial of adjunctive EPA in OCD","volume":"38","author":"Fux","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1192\/bjp.181.1.22","article-title":"Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behavior of young adult prisoners: randomized, placebo-controlled trial","volume":"181","author":"Gesch","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.euroneuro.2005.07.005","article-title":"Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder","volume":"16","author":"Green","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI118507","article-title":"The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study","volume":"97","author":"Hamazaki","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11745-998-0254-2","article-title":"Docosahexaenoic acid does not affect aggression of normal volunteers under nonstressful conditions. A randomized, placebo-controlled, double-blind study","volume":"33","author":"Hamazaki","year":"1998","journal-title":"Lipids"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10284150290007119","article-title":"The effect of docosahexaenoic acid on aggression in elderly Thai subjects \u2014 a placebo-controlled double-blind study","volume":"5","author":"Hamazaki","year":"2002","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(05)79168-6","article-title":"Fish consumption and major depression [letter]","volume":"35","author":"Hibbeln","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000059747","article-title":"Seafood consumption and homicide mortality: a cross-national ecological analysis","volume":"88","author":"Hibbeln","year":"2001","journal-title":"World Rev Nutr Diet"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0165-0327(01)00374-3","article-title":"Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis","volume":"69","author":"Hibbeln","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-3223(98)00141-3","article-title":"Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics","volume":"44","author":"Hibbeln","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"Suppl 6","key":"10.1016\/j.pnpbp.2007.10.020_bib18","doi-asserted-by":"crossref","first-page":"1483S","DOI":"10.1093\/ajcn\/83.6.1483S","article-title":"Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity","volume":"83","author":"Hibbeln","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib19","series-title":"Recommendations for Dietary Intake of Polyunsaturated Fatty Acids in Healthy Adults","author":"International Society for the Study of Fatty Acids and Lipids","year":"2004"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.ejcn.1601739","article-title":"Dietary intake of n-3, n-6 fatty acids and fish: Relationship with hostility in young adults \u2014 the CARDIA study","volume":"58","author":"Iribarren","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","article-title":"Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder","volume":"60","author":"Keck","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1530-0277.2007.00442.x","article-title":"Alcohol consumption and fatty acid intakes in the 2001\u20132002 National Health and Nutrition Examination Survey","volume":"31","author":"Kim","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib23","series-title":"Antioxidants in Nutrition and Health","first-page":"299","article-title":"Alcoholism, antioxidant status and essential fatty acids","author":"Lands","year":"1998"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib24","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1194\/jlr.D500022-JLR200","article-title":"A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies","volume":"46","author":"Masood","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib26","series-title":"Manual for the Profile of Mood States","author":"McNair","year":"1971"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib27","series-title":"Diet History Questionnaire DHQ-1 2002","article-title":"US National Institutes of Health","author":"National Cancer Institute","year":"2002"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib29","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.160.12.2222","article-title":"Cross-national comparisons of seafood consumption and rates of bipolar disorders","volume":"160","author":"Noaghiul","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib31","series-title":"Handbook of Essential Fatty Acid Biology: Biochemistry, Physiology, and Behavioral Neurobiology","first-page":"67","article-title":"Abnormalities in essential fatty acid status in alcoholism","author":"Salem","year":"1997"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s11745-001-0805-6","article-title":"Mechanisms of action of docosahexaenoic acid in the nervous system","volume":"36","author":"Salem","year":"2001","journal-title":"Lipids"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"Coll Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2007.10.020_bib34","first-page":"391","article-title":"Omega 3 fatty acids and the brain: review of studies in depression","volume":"16","author":"Sinclair","year":"2007","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10253890410001667188","article-title":"Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats","volume":"7","author":"Song","year":"2004","journal-title":"Stress"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial","volume":"56","author":"Stoll","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","article-title":"Omega-3 fatty acids in major depressive disorder: a preliminary double-blind, placebo-controlled trial","volume":"13","author":"Su","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib38","series-title":"Nutrient Data Laboratory Home Page","article-title":"Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 17","author":"U.S. Department of Agriculture","year":"2004"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib39","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0006-3223(87)90051-5","article-title":"Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders","volume":"22","author":"Virkkunen","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/10284150500445795","article-title":"Mixture of essential fatty acids lowers test anxiety","volume":"8","author":"Yehuda","year":"2005","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/rnd:2005001","article-title":"Omega-3 fatty acids and neuropsychiatric disorders","volume":"45","author":"Young","year":"2005","journal-title":"Reprod Nutr Dev"},{"key":"10.1016\/j.pnpbp.2007.10.020_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.ajp.160.1.167","article-title":"Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study","volume":"160","author":"Zanarini","year":"2003","journal-title":"Am J Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607003880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607003880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T04:18:57Z","timestamp":1556943537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584607003880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0278584607003880"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.10.020","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}